Gina Sevigny, MD
MOHS-Micrographic Surgery · Ormond Beach, FLNPI 1245399237
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.7%), food and beverage and education — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by AbbVie at 54.3% of the total.
Across 154 payments — averaging $32.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Almirall LLC$301
- Johnson & Johnson$289
- Sun Pharmaceutical Industries Inc.$258
- Incyte Corporation$169
- Pfizer$158
- plus $1K from 19 others
What the payments were for
- Speaking & faculty fees$2,55851%
- Food & beverage$2,47749%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 43 | $2,740 |
| Almirall LLC | 13 | $301 |
| Johnson & Johnson | 13 | $289 |
| Sun Pharmaceutical Industries Inc. | 12 | $258 |
| Incyte Corporation | 8 | $169 |
| Pfizer | 10 | $158 |
| Amgen | 6 | $137 |
| E.r. Squibb & Sons, L.L.C. | 5 | $119 |
| Galderma Laboratories, L.p. | 6 | $105 |
| Regeneron Healthcare Solutions, Inc. | 5 | $105 |
| Novartis | 6 | $98 |
| LEO Pharma Inc. | 4 | $85 |
| Bristol Myers Squibb | 3 | $71 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $57 |
| Lilly USA, LLC | 3 | $57 |
| Sanofi | 2 | $51 |
| Organogenesis Inc. | 1 | $47 |
| VYNE Pharmaceuticals Inc. | 2 | $39 |
| Biofrontera Inc. | 2 | $38 |
| Mimedx Group, Inc. | 2 | $28 |
| Mayne Pharma Commercial LLC | 1 | $25 |
| Smith+Nephew | 1 | $24 |
| Merck | 1 | $21 |
| Genentech USA, Inc. | 1 | $15 |
| Strata Skin Sciences, Inc. | 1 | $12 |
How this compares
$5,050 in reported general payments places this provider in the 75th percentile of 141 mohs-micrographic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 50 | $3,308 |
| Metronidazole | 38 | $1,996 |
| Triamcinolone Acetonide | 144 | $1,377 |
| Ketoconazole | 72 | $1,310 |
| Clobetasol Propionate | 36 | $1,269 |
| Ciclopirox | 24 | $598 |
| Doxycycline Hyclate | 46 | $570 |
| Clindamycin Phosphate | 19 | $539 |
| Hydrocortisone | 81 | $503 |
| ValacyclovirValacyclovir Hcl | 33 | $286 |
| Mupirocin | 40 | $268 |
| Nystatin | 11 | $198 |
| Minocycline Hcl | 14 | $136 |
| Amoxicillin | 47 | $128 |
| Clindamycin Hcl | 19 | $59 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Ormond Beach
- Andrew WeinsteinBoynton Beach$197K
- Armand CognettaTallahassee$139K
- Scott FoskoGainesville$100K
- Paul BenedettoCoral Springs$96K
- Jeremy SunseriPanama City$81K
- Shawna FlanaganJupiter$74K
- Martin ZaiacMiami Beach$61K
- Jason RizzoEstero$60K
- Andrew JaffePalm Beach Gardens$52K
- Kenneth WallaceOcala$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.